Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 3/2019

01-06-2019 | Computed Tomography | Case Report

Esophageal carcinosarcoma that disappeared pathologically by palliative radiotherapy alone

Authors: Keiichi Kimura, Yoshito Hayashi, Keisuke Otani, Yoshiki Tsujii, Hideki Iijima, Fumiaki Isohashi, Kazuhiko Ogawa, Tetsuo Takehara

Published in: Clinical Journal of Gastroenterology | Issue 3/2019

Login to get access

Abstract

Only a few cases of esophageal granulocyte-colony-stimulating-factor (G-CSF)–producing esophageal carcinosarcoma are reported, and patients with G-CSF–producing tumors are typically considered to have poor prognosis. An 89-year-old man was examined for low-grade fever and dysphagia. Chest computed tomography revealed a huge 80-mm tumor on the thoracic esophagus without direct invasion to surrounding organs. Esophagogastroduodenoscopy (EGD) showed a huge mass occupying the esophageal lumen with a superficial flat lesion. Histopathological examination revealed that the tumor was composed of bizarre giant cells and pleomorphic spindle cells with hyperchromatic nuclei. Laboratory data showed aberrant elevation of leukocyte and neutrophil counts and G-CSF levels. The tumor was finally diagnosed as a G-CSF-producing esophageal carcinosarcoma, stage II (T2N0M0, Union for International Cancer Control-TNM Classification of Malignant Tumors, 8th edition). Considering his general condition, we performed palliative radiotherapy (45 Gy/15 fr) alone after consultation with surgeons and radiation oncologists. Follow-up EGD demonstrated the disappearance of the tumor, and the histological assessment of biopsy specimens confirmed no evidence of malignancy. The leukocyte count and G-CSF levels decreased within normal range. This is a very rare case of G-CSF-producing esophageal carcinosarcoma in which a pathologically complete response was achieved using palliative radiotherapy alone.
Literature
1.
go back to reference Iyomasa S, Kato H, Tachimori Y, et al. Carcinosarcoma of the esophagus: a twenty-case study. Jpn J Clin Oncol. 1990;20:99–106.PubMed Iyomasa S, Kato H, Tachimori Y, et al. Carcinosarcoma of the esophagus: a twenty-case study. Jpn J Clin Oncol. 1990;20:99–106.PubMed
2.
go back to reference Matsutani T, Nomura T, Hagiwara N, et al. A case of carcinosarcoma of the esophagus detected on fluorodeoxyglucose positron emission tomography. J Nippon Med Sch. 2014;81:401–5.CrossRefPubMed Matsutani T, Nomura T, Hagiwara N, et al. A case of carcinosarcoma of the esophagus detected on fluorodeoxyglucose positron emission tomography. J Nippon Med Sch. 2014;81:401–5.CrossRefPubMed
3.
go back to reference Ogasawara N, Tamura Y, Funaki Y, et al. Rapidly growing esophageal carcinosarcoma reduced by neoadjuvant radiotherapy alone. Case Rep Gastroenterol. 2014;8:227–34.CrossRefPubMedPubMedCentral Ogasawara N, Tamura Y, Funaki Y, et al. Rapidly growing esophageal carcinosarcoma reduced by neoadjuvant radiotherapy alone. Case Rep Gastroenterol. 2014;8:227–34.CrossRefPubMedPubMedCentral
4.
go back to reference Sanada Y, Hihara J, Yoshida K, et al. Esophageal carcinosarcoma with intramural metastasis. Dis Esophagus. 2006;19:119–31.CrossRefPubMed Sanada Y, Hihara J, Yoshida K, et al. Esophageal carcinosarcoma with intramural metastasis. Dis Esophagus. 2006;19:119–31.CrossRefPubMed
5.
go back to reference Patricia S, Saikat D, Rajesh B, et al. Rare cause of stricture esophagus-sarcoma: a case report and review of the literature. Case Rep Gastrointest Med. 2011; 2011:192423.PubMedPubMedCentral Patricia S, Saikat D, Rajesh B, et al. Rare cause of stricture esophagus-sarcoma: a case report and review of the literature. Case Rep Gastrointest Med. 2011; 2011:192423.PubMedPubMedCentral
6.
go back to reference Kobayashi S, Nagata Y, Tokai H, et al. Multidisciplinary therapy for granulocyte-colony-stimulating factor producing carcinosarcoma of the esophagus: report of a case. Clin Case Rep. 2015;3:681–5.CrossRefPubMedPubMedCentral Kobayashi S, Nagata Y, Tokai H, et al. Multidisciplinary therapy for granulocyte-colony-stimulating factor producing carcinosarcoma of the esophagus: report of a case. Clin Case Rep. 2015;3:681–5.CrossRefPubMedPubMedCentral
7.
go back to reference Ota S, Kato A, Kobayashi H, et al. Monoclonal origin of an esophageal carcinosarcoma producing granulocyte-colony stimulating factor: a case report. Cancer. 1998;82:2102–11.CrossRefPubMed Ota S, Kato A, Kobayashi H, et al. Monoclonal origin of an esophageal carcinosarcoma producing granulocyte-colony stimulating factor: a case report. Cancer. 1998;82:2102–11.CrossRefPubMed
8.
go back to reference Maejima K, Watanabe M, Komine O, et al. Granulocyte-colony stimulating factor-producing esophageal carcinosarcoma: a case report. Esophagus. 2007;4:117–20.CrossRef Maejima K, Watanabe M, Komine O, et al. Granulocyte-colony stimulating factor-producing esophageal carcinosarcoma: a case report. Esophagus. 2007;4:117–20.CrossRef
9.
go back to reference Sasaki K, Natsugoe S, Higashi M, et al. Esophageal carcinosarcoma with granulocyte colony-stimulating factor: a case report. Esophagus. 2007;4:129–34.CrossRef Sasaki K, Natsugoe S, Higashi M, et al. Esophageal carcinosarcoma with granulocyte colony-stimulating factor: a case report. Esophagus. 2007;4:129–34.CrossRef
10.
go back to reference Miyamoto K, Shibata S, Kawasaki H. Carcinosarcoma of the esophagus producing granulocyte-colony stimulating factor: report of a case. Esophagus. 2008;5:171–5.CrossRef Miyamoto K, Shibata S, Kawasaki H. Carcinosarcoma of the esophagus producing granulocyte-colony stimulating factor: report of a case. Esophagus. 2008;5:171–5.CrossRef
11.
go back to reference Cha RR, Jung WT, Oh HW, et al. A case of metachronous development of esophageal squamous cell carcinoma in the patient with esophageal carcinosarcoma. Korean J Gastroenterol. 2014;64:364–9.CrossRefPubMed Cha RR, Jung WT, Oh HW, et al. A case of metachronous development of esophageal squamous cell carcinoma in the patient with esophageal carcinosarcoma. Korean J Gastroenterol. 2014;64:364–9.CrossRefPubMed
12.
13.
go back to reference Adan AK, Long AE, Weldon CB, et al. Esophageal carcinosarcoma. J Gastrointest Surg. 2001;5:414–7.CrossRef Adan AK, Long AE, Weldon CB, et al. Esophageal carcinosarcoma. J Gastrointest Surg. 2001;5:414–7.CrossRef
14.
go back to reference Akagi I, Miyashita M, Makino H, et al. So-called carcinosarcoma of the esophagus: report of a case. J Nippon Med Sch. 2008;75:171–4.CrossRefPubMed Akagi I, Miyashita M, Makino H, et al. So-called carcinosarcoma of the esophagus: report of a case. J Nippon Med Sch. 2008;75:171–4.CrossRefPubMed
15.
go back to reference Iascone C, Barreca M. Carcinosarcoma and pseudosarcoma of the esophagus: two names, one disease–comprehensive review of the literature. World J Surg. 1999;23:153–7.CrossRefPubMed Iascone C, Barreca M. Carcinosarcoma and pseudosarcoma of the esophagus: two names, one disease–comprehensive review of the literature. World J Surg. 1999;23:153–7.CrossRefPubMed
16.
go back to reference Zhang B, Xiao Q, Yang D, et al. Spindle cell carcinoma of the esophagus: a multicenter analysis in comparison with typical squamous cell carcinoma. Medicine (Baltimore). 2016;95:e4768.CrossRef Zhang B, Xiao Q, Yang D, et al. Spindle cell carcinoma of the esophagus: a multicenter analysis in comparison with typical squamous cell carcinoma. Medicine (Baltimore). 2016;95:e4768.CrossRef
17.
go back to reference Wang L, Lin Y, Long H, et al. Esophageal carcinosarcoma: a unique entity with better prognosis. Ann Surg Oncol. 2013;20:997–1004.CrossRefPubMed Wang L, Lin Y, Long H, et al. Esophageal carcinosarcoma: a unique entity with better prognosis. Ann Surg Oncol. 2013;20:997–1004.CrossRefPubMed
18.
go back to reference Penniment MG, De Ieso PB, Harvey JA, et al. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01). Lancet Gastroenterol Hepatol. 2018;3:114–24.CrossRefPubMed Penniment MG, De Ieso PB, Harvey JA, et al. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01). Lancet Gastroenterol Hepatol. 2018;3:114–24.CrossRefPubMed
19.
go back to reference Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16:187–99.CrossRefPubMedPubMedCentral Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16:187–99.CrossRefPubMedPubMedCentral
20.
21.
go back to reference Kingsley DP. An interesting case of possible abscopal effect in malignant melanoma. Br J Radiol. 1975;48:863–6.CrossRefPubMed Kingsley DP. An interesting case of possible abscopal effect in malignant melanoma. Br J Radiol. 1975;48:863–6.CrossRefPubMed
22.
go back to reference Bruton Joe M, Truong PT, et al Abscopal effect after palliative radiation therapy for metastatic adenocarcinoma of the esophagus. Cureus 2018; 10(8):e3089.PubMedPubMedCentral Bruton Joe M, Truong PT, et al Abscopal effect after palliative radiation therapy for metastatic adenocarcinoma of the esophagus. Cureus 2018; 10(8):e3089.PubMedPubMedCentral
23.
go back to reference Takahashi Y, Yasui T, Tamari K, et al. Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma. PLoS One. 2017;12:e0189697.CrossRefPubMedPubMedCentral Takahashi Y, Yasui T, Tamari K, et al. Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma. PLoS One. 2017;12:e0189697.CrossRefPubMedPubMedCentral
Metadata
Title
Esophageal carcinosarcoma that disappeared pathologically by palliative radiotherapy alone
Authors
Keiichi Kimura
Yoshito Hayashi
Keisuke Otani
Yoshiki Tsujii
Hideki Iijima
Fumiaki Isohashi
Kazuhiko Ogawa
Tetsuo Takehara
Publication date
01-06-2019
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 3/2019
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-00933-7

Other articles of this Issue 3/2019

Clinical Journal of Gastroenterology 3/2019 Go to the issue